Assessing the use of anti-PD1 monotherapy as adjuvant therapy and determinants of treatment choice in stage III cutaneous melanoma in the US

Whitman, Eric D ; Totev, Todor I ; Jiang, Shan ; da Costa, Jr, Wilson L ; Grebennik, Dmitri ; Wang, Hongjue ; Boca, Andra-Ecaterina ; Ayyagari, Rajeev

BMC cancer, 2024-03, Vol.24 (1), p.389-389, Article 389 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível